Risk of synchronous and second primary malignancies in transplant-ineligible patients with multiple myeloma treated with lenalidomide
接受来那度胺治疗的多发性骨髓瘤患者(不适合移植)发生同步性恶性肿瘤和第二原发性恶性肿瘤的风险
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2025016625
Systchenko, Thomas; Nsiala, Laly; Bobin, Arthur; Gardeney, Hélène; Motard, Carine; Olivier, Gaelle; Borde, Florence; Corby, Anne; Roul, Christophe; Fleck, Emmanuel; Denis, Guillaume; Dieval, Céline; Mottaz, Philippe; Boscagli, Annick; Defossez, Gautier; Leleu, Xavier